Atrium Therapeutics
Earnings Surprise
Analysts estimated RNA earnings of $-1.06 per share this quarter (Q1). RNA's actual earnings were $-0.97 per share.
RNA EPS surprise of 8.53%Analysts estimated RNA earnings of $-1.11 per share this quarter (Q3). RNA's actual earnings were $-1.27 per share.
RNA EPS surprise of -14.20%Analysts estimated RNA earnings of $-1.00 per share this quarter (Q2). RNA's actual earnings were $-1.21 per share.
RNA EPS surprise of -21.39%Analysts estimated RNA earnings of $-0.72 per share this quarter (Q3). RNA's actual earnings were $-0.65 per share.
RNA EPS surprise of 9.53%Analysts estimated RNA earnings of $-0.80 per share this quarter (Q2). RNA's actual earnings were $-0.65 per share.
RNA EPS surprise of 18.67%Analysts estimated RNA earnings of $-0.67 per share this quarter (Q4). RNA's actual earnings were $-0.79 per share.
RNA EPS surprise of 18.51%Analysts estimated RNA earnings of $-0.78 per share this quarter (Q3). RNA's actual earnings were $-0.71 per share.
RNA EPS surprise of -8.47%